Radiosensitivity Enhancement by Combined Treatment of Nimotuzumab and Celecoxib on Nasopharyngeal Carcinoma Cells [Retraction]
Drug Design, Development and Therapy · 2026-04 · Volume 20 · 1-1
DOI: 10.2147/dddt.s614698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-04. Verfasst von Jianfeng Huang und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Huang, J., Yuan, X., Pang, Q., Zhang, H., Yu, J., Yang, B., Zhou, L., Zhang, F., & Liu, F. (2026). Radiosensitivity Enhancement by Combined Treatment of Nimotuzumab and Celecoxib on Nasopharyngeal Carcinoma Cells [Retraction]. Drug Design, Development and Therapy, Volume 20, 1-1. https://doi.org/10.2147/dddt.s614698
Vancouver
Huang J, Yuan X, Pang Q, Zhang H, Yu J, Yang B, et al. Radiosensitivity Enhancement by Combined Treatment of Nimotuzumab and Celecoxib on Nasopharyngeal Carcinoma Cells [Retraction]. Drug Design, Development and Therapy. 2026;Volume 20:1-1. doi:10.2147/dddt.s614698
BibTeX
@article{Huang2026,
author = {Huang, Jianfeng and Yuan, Xiaopeng and Pang, Qingfeng and Zhang, Haowen and Yu, Jiahua and Yang, Bo and Zhou, Leyuan and Zhang, Fuzheng and Liu, Fenju},
title = {Radiosensitivity Enhancement by Combined Treatment of Nimotuzumab and Celecoxib on Nasopharyngeal Carcinoma Cells [Retraction]},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--1},
doi = {10.2147/dddt.s614698}
}
EUVIMED